نتائج البحث 741-750 من 4940 لعملية البحث عن Blood factor II
... 2-hydroxyglutarate (2HG) and, therefore ... factors associated with onset of symptoms in MSA. ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه للصفحة 44 ...
Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). ... Human Blood and ...
Although some fetuses present with arrhythmias easily recognized as LQTS (torsade des pointes (TdP) and/or 2 ... Determine risk factors for sarcoid involvement of ...
... II). Additinoally, to evaluate the effectiveness ... blood samples) are predictors of treatment success. ... The primary purpose of the phase II study is ...
The purpose of this study is to develop prognostic and diagnostic blood ... We further examine whether blood biomarkers can ... 2-year progression free survival ( ...
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...
... II). Additinoally, to evaluate the effectiveness by overall response rate (ORR – defined as confirmed and unconfirmed partial responses plus complete ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.